AIDS Therapies

Brazil Withdraws Threat To Ignore Drug Patents

Published in AIDS Weekly, September 17th, 2001

Brazil withdrew its threat to ignore patents and start making a generic version of a powerful AIDS drug after a Swiss pharmaceutical giant promised to slash prices by 40%.

Health Minister Jose Serra, who had pledged to start making the drug Nelfinavir at Brazil's state-owned Far-Manguinhos laboratory, announced a last-minute agreement had been reached with the drug's manufacturer, Roche group of Switzerland.

The Swiss pharmaceutical giant had agreed to reduce the price of Nelfinavir in Brazil by 40%, to US$0.64 per unit, Serra said, adding, "With the deal, it's cheaper to buy from Roche than to produce the drug.''

"We are pleased...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2001-09-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry